Jim Glasheen
Founder at Clade Therapeutics, Inc.
Profile
Jim Glasheen was the founder of Atalanta Therapeutics, Inc. which he founded in 2018 and where he held the titles of President, Chief Executive Officer & Director until 2020.
He is also the founder of Clade Therapeutics, Inc. Dr. Glasheen's current jobs include Managing Director at First Citizens Bank Ltd.
and Venture Partner at CHP Management, Inc. Dr. Glasheen's education includes an undergraduate degree from Duke University and graduate and doctorate degrees from Harvard University.
Jim Glasheen active positions
Companies | Position | Start |
---|---|---|
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Founder | - |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Private Equity Investor | - |
First Citizens Bank Ltd.
First Citizens Bank Ltd. Major BanksFinance First Citizens Bank Ltd. engages in the provision of financial services. It operates through the following segments: Retail Banking, Corporate Banking, Treasury Management and Investment Banking, Asset Management, and Group Function. The Retail Banking segment includes loans and mortgages, deposit, foreign exchange transactions, credit and debit cards, and card merchant acquiring business with retail and commercial customers. The Corporate Banking segment offers loans and credit facilities, and deposits and current accounts for corporate and institutional customers. The Treasury Management and Investment Banking segment comprises of liquidity management and investment banking services as well as corporate finance, and specialized financial trading. The Asset Management segment consists of investment products and services to institutional investors and intermediaries. The Group Function segment involves in finance, legal, and other centralized functions. The company was founded in March 1993 and is headquartered in Port of Spain, Trinidad and Tobago. | Director/Board Member | - |
Former positions of Jim Glasheen
Companies | Position | End |
---|---|---|
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Founder | 2020-12-30 |
Training of Jim Glasheen
Duke University | Undergraduate Degree |
Harvard University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Clade Therapeutics, Inc.
Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation. | Health Technology |
CHP Management, Inc.
CHP Management, Inc. Investment ManagersFinance CHP Management Inc (Cardinal Partners) is a venture capital firm founded in 1996 by John K Clarke, Brandon H Hull and John J Park. The firm is headquartered in Princeton, New Jersey. | Finance |
Atalanta Therapeutics, Inc.
Atalanta Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Atalanta Therapeutics, Inc. develops RNA interference based therapeutics to treat neurodegenerative diseases. The company is based in Boston, MA. The company was founded by Neil Aronin, Craig C. Mello, Anastasia Khvorova, Jim Glasheen. The CEO is Alicia Secor. | Commercial Services |
First Citizens Bank Ltd.
First Citizens Bank Ltd. Major BanksFinance First Citizens Bank Ltd. engages in the provision of financial services. It operates through the following segments: Retail Banking, Corporate Banking, Treasury Management and Investment Banking, Asset Management, and Group Function. The Retail Banking segment includes loans and mortgages, deposit, foreign exchange transactions, credit and debit cards, and card merchant acquiring business with retail and commercial customers. The Corporate Banking segment offers loans and credit facilities, and deposits and current accounts for corporate and institutional customers. The Treasury Management and Investment Banking segment comprises of liquidity management and investment banking services as well as corporate finance, and specialized financial trading. The Asset Management segment consists of investment products and services to institutional investors and intermediaries. The Group Function segment involves in finance, legal, and other centralized functions. The company was founded in March 1993 and is headquartered in Port of Spain, Trinidad and Tobago. | Finance |
- Stock Market
- Insiders
- Jim Glasheen